These in vitro findings were confirmed in vivo using a mouse vaccination tumor model where they demonstrated that melanoma tumors with high ATX expression had less infiltrating CD8+ T cells compared to melanoma tumors with low ATX expression. This evidence concerns the gene CD8A and neoplasm.